Vial sizes change
Due to the aggressiveness of their chemical components (which can be toxic to our skin), they are being discontinued to the detriment of other types more respectful of our skin
These are not your everyday on site drug tests
If you want specific sources to read, check the New England Journal of Medicine trial on GLP1 agents for metabolic outcomes, the 2024 JAMA Internal Medicine paper on semaglutide and mental health, the 2024 Scientific Reports analysis, and recent reviews by regulatory agencies and psychiatry meetings that discuss case reports and signal detection
Five trials focused on participants with cardiovascular disease or risk factors, three trials included participants with cardiovascular disease alone, one trial enrolled those with cardiovascular or kidney disease and additional risk factors, and one included participants regardless of cardiovascular history
Start Your Weight Loss Journey Today Book a consultation with our board-certified team to discuss whether Trulicity, Mounjaro, or another GLP-1 medication is the right fit for your goals